Springhill Fund Asset Management (Hk) CO LTD Portfolio Holdings

Springhill Fund Asset Management (Hk) CO LTD

  • $61.6 Billion
  • Q4 2024

Springhill Fund Asset Management (Hk) CO LTD has filed its 13F form on February 13, 2025 for Q4 2024 where it was disclosed a total value porftolio of $61.6 Billion distributed in 17 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Verona Pharma PLC with a value of $6.29B, Legend Biotech Corp with a value of $6.21B, Cytokinetics Inc with a value of $6.15B, Astrazeneca PLC with a value of $5.01B, and Insmed Inc with a value of $4.8B.

Examining the 13F form we can see an increase of $61.6B in the current position value.

Springhill Fund Asset Management (Hk) CO LTD is based out at Hong Kong, K3

Below you can find more details about Springhill Fund Asset Management (Hk) CO LTD portfolio as well as his latest detailed transactions.

Portfolio value $61.6 Billion
Healthcare: $57.8 Billion

Stock Holdings Table Market Cap. of $50 Millions to $300 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 17
  • Current Value $61.6 Billion
  • Filing
  • Period Q4 2024
  • Filing Date February 13, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 17 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Springhill Fund Asset Management (Hk) CO LTD Portfolio

Follow Springhill Fund Asset Management (Hk) CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Springhill Fund Asset Management (Hk) CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Springhill Fund Asset Management (Hk) CO LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email